Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/25/2025

Risk of Psychosis with Antidepressants in Schizoaffective Disorder

Mechanism and Risk

  • SSRIs like fluoxetine and sertraline can exacerbate psychotic symptoms in patients with schizoaffective disorder, particularly when used without concurrent antipsychotic medication 1, 2

Evidence from Clinical Guidelines

  • Discontinuation of antipsychotic medication in schizoaffective disorder significantly increases the risk of symptom recurrence and hospitalization 3, 4
  • Guidelines recommend that patients with schizoaffective disorder should not stop their antipsychotic medication without proper cross-titration to an alternative antipsychotic if needed 1, 2

Management Recommendations

  • Reinstate antipsychotic treatment immediately to prevent full psychotic relapse 1, 2
  • If antidepressant treatment is necessary for depressive symptoms in schizoaffective disorder, it should only be initiated after antipsychotic treatment has been established 5

Special Considerations

  • Long-acting injectable antipsychotics may be beneficial for patients with adherence issues to prevent future medication discontinuation 6, 7